Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Authors

Alexis Ogdie (ORCID: https://orcid.org/0000-0002-4639-0775)
Rajiv Mundayat (ORCID: https://orcid.org/0000-0002-0005-0169)
Nicole Middaugh
Taylor Blachley (ORCID: https://orcid.org/0000-0002-7632-1957)
Tran Bourgeois (ORCID: https://orcid.org/0000-0002-0315-3200)
Karim Richard Masri (ORCID: https://orcid.org/0000-0002-2178-9747)
Philip J. Mease (ORCID: https://orcid.org/0000-0002-6620-0457)
Lara Fallon (ORCID: https://orcid.org/0000-0001-7113-1014)
You‐Li Ling

Institutions

Pfizer (United States) (US)
Swedish Medical Center (US)
Pfizer (Canada) (CA)
University of Pennsylvania (US)

Publication Details

Journal: Rheumatology and Therapy
Published: 2025-12-04
DOI: https://doi.org/10.1007/s40744-025-00811-4
Primary Topic: Spondyloarthritis Studies and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Rheumatology Research Foundation
Children's Hospital of Philadelphia
Ortho Dermatologics
LEO Pharma
National Institutes of Health
Genentech
Chugai Pharmaceutical
National Institute of Arthritis and Musculoskeletal and Skin Diseases

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Alexis Ogdie, Rajiv Mundayat, Nicole Middaugh, Taylor Blachley et al.

Dec 4, 2025

Rheumatology and Therapy

Spondyloarthritis Studies and Treatments

article

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Alexis Ogdie, Rajiv Mundayat, Nicole Middaugh, Taylor Blachley, Tran Bourgeois, Karim Richard Masri, Philip J. Mease, Lara Fallon, You‐Li Ling

December 4, 2025article en

Abstract

No abstract available for this paper.

Rheumatology and TherapyVol. 13(1)

Pfizer (United States) (US), Swedish Medical Center (US), Pfizer (Canada) (CA), University of Pennsylvania (US)

Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Rheumatology Research Foundation, Children's Hospital of Philadelphia, Ortho Dermatologics, LEO Pharma, National Institutes of Health, Genentech, Chugai Pharmaceutical, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Openalex Percentile: Top 45%

Spondyloarthritis Studies and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry — Alexis Ogdie, Rajiv Mundayat, et al. · Rheumatology and Therapy (2025) | TGRS Research Map | TGRS